Skip to content

Clinical trials

Completed Atypical Hemolytic Uremic Syndrome trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atypical Hemolytic Uremic Syndrome Status: Completed Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20095
20102
20122
20141
20151
20161
20172
20181
20191
20211
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.11
AO GENERIUM1
Amgen1
AstraZeneca1
Children's Hospital Medical Center, Cincinnati1
Nantes University Hospital1
Novartis Pharmaceuticals1
Omeros Corporation1
University Hospital, Tours1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atypical Hemolytic Uremic Syndrome19
Thrombotic Microangiopathies5
Kidney Diseases3
Hemolytic-Uremic Syndrome2
Anemia1
Anemia, Hemolytic1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Azotemia1
Blood Platelet Disorders1
Disease1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.